Fri.Jan 21, 2022

article thumbnail

Global digital health funding skyrockets to $57.2B with record cash for mental health, telehealth

Fierce Healthcare

Global digital health funding skyrockets to $57.2B with record cash for mental health, telehealth. hlandi. Fri, 01/21/2022 - 11:17.

143
143
article thumbnail

Covid vaccine booster raises antibody levels in fight against Omicron

pharmaphorum

A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron. Details of the study were published in The Lancet this week. UCLH researchers stated that antibodies generated in people who had received only two doses of either the Oxford/AstraZeneca vaccine or the Pfizer/BioNTech vaccin

Vaccines 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cigna study: Virtual care can reduce unnecessary ER, urgent care visits by 19%

Fierce Healthcare

Cigna study: Virtual care can reduce unnecessary ER, urgent care visits by 19%. pminemyer. Fri, 01/21/2022 - 14:24.

145
145
article thumbnail

Biliary tract cancer drug granted orphan drug designation in US

pharmaphorum

The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation. There are currently no treatments for this rare cancer, and the US food and Drug Administration (FDA) hopes that pharmaceutical firm Senhwa’s drug will meet the significant need for new biliary tract cancer options. First-line standard of care is currently a chemotherapy regimen of gemcitabine and the powerful intravenous drug cisplatin However, there are no globally accepted standards of care for lo

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

IBM sells Watson Health assets to investment firm Francisco Partners

Fierce Healthcare

IBM sells Watson Health assets to investment firm Francisco Partners. hlandi. Fri, 01/21/2022 - 09:44.

144
144
article thumbnail

Japan approves Pfizer COVID vaccine for children aged 5 to 11

pharmaphorum

Japan’s health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five and 11. The vaccine, Comirnaty, is claimed to be the first in Japan to be approved for use in this age group. Once the Ministry of Health, Labor and Welfare grants special approval, Japan will join the UK and US in efforts to reduce the impact of COVID-19 in children.

More Trending

article thumbnail

Life Sciences Predictions for 2022

pharmaphorum

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.

52
article thumbnail

KFF: 4 out of 13 major insurers rely on mail and faxes to reimburse at-home COVID-19 tests

Fierce Healthcare

KFF: 4 out of 13 major insurers rely on mail and faxes to reimburse at-home COVID-19 tests. rking. Fri, 01/21/2022 - 11:05.

Insurance 115
article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry. And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccin

article thumbnail

Encompass Health to spin off home health, hospice business as new company

Fierce Healthcare

Encompass Health to spin off home health, hospice business as new company. dmuoio. Fri, 01/21/2022 - 12:20.

110
110
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Learn How to Lose Weight with These Surprising Tips

Tria Health Blog

Losing weight can sometimes feel like the easy part in your weight loss journey. The hard part is keeping that weight off and being consistent in your weight loss goals.

52
article thumbnail

Encompass Health sets July 1 target for its home health, hospice spinoff

Fierce Healthcare

Encompass Health sets July 1 target for its home health, hospice spinoff. dmuoio. Fri, 01/21/2022 - 14:08.

52
article thumbnail

Scandi pharma: Swede deal for Psyros Diagnostics

Pharma Times

Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology enables the measurement of disease-indicating molecules in extremely low concentrations–in ten minutes or less.

49
article thumbnail

Pharmacist vacancies highlight need for funding booster

Pharma Times

New figures from Health Education England (HEE) show that the pharmacist vacancy rate in community pharmacies across England has doubled to 8% between 2017 and 2021.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.